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The transforming growth factor- (TGF-) superfamily contains a variety of growth factors which all share common sequence
elements and structural motifs. These proteins are known to exert a wide spectrum of biological responses on a large variety of
cell types in both vertebrates and invertebrates. Many of them have important functions during embryonic development in
pattern formation and tissue specification, and in adult tissues, they are involved in processes such as wound healing, bone repair,
and bone remodeling. The family is divided into two general branches: the BMP/GDF and the TGF-/Activin/Nodal branches,
whose members have diverse, often complementary effects. It is obvious that an orchestered regulation of different actions of
these proteins is necessary for proper functioning. The TGF- family members act by binding extracellularly to a complex of
serine/threonine kinase receptors, which consequently activate Smad molecules by phosphorylation. These Smads translocate to
the nucleus, where they modulate transcription of specific genes. Three levels by which this signaling pathway is regulated could
be distinguished. First, a control mechanism exists in the intracellular space, where inhibitory Smads and Smurfs prevent further
signaling and activation of target genes. Second, at the membrane site, the pseudoreceptor BAMBI/Nma is able to inhibit further
signaling within the cells. Finally, a range of extracellular mediators are identified which modulate the functioning of members
of the TGF- superfamily. Here, we review the insights in the extracellular regulation of members of the BMP subfamily of
secreted growth factors with a major emphasis on vertebrate BMP modulation. © 2002 Elsevier Science (USA)
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Bone morphogenetic proteins (BMPs) are secreted growth
factors, which, based on amino acid homology of a highly
conserved seven-cysteine domain in the carboxy-terminal
region of the proteins, form a subgroup of the transforming
growth factor- (TGF-) superfamily (Kingsley, 1994). They
are dimeric proteins with a single interchain disulfide bond,
and this dimeric conformation is an absolute requirement
for the biological action of BMPs (Eimon and Harland,
1999). BMPs were originally isolated by their ability to
induce ectopic bone and cartilage formation in vivo (Urist,
1965), but it became rapidly evident that BMPs also act as
multifunctional regulators in morphogenesis during devel-
opment in vertebrates and invertebrates (reviewed in
Hogan, 1996a,b; Graff, 1997; Ebendal et al., 1998; Wozney,
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All rights reserved.1998). More than 30 BMP family members have already
been described. They have been classified into several
subgroups according to their structural similarities. Indi-
vidually, the members of this TGF- subfamily are termed
BMPs, osteogenic proteins (OPs), cartilage-derived morpho-
genetic proteins (CDMPs), and growth and differentiation
factors (GDFs) (Ducy and Karsenty, 2000), and also include
BMP-like molecules from various species, including the fly
Drosophila melanogaster [decapentaplegic (dpp); 60A-glass
bottom boat (gbb); and Screw]) and the frog Xenopus laevis
(Vg1). In the nematode Caenorhabditis elegans, three BMP-
like pathways have been characterized: the dauer; Sma/
Mab; and unc-129 pathways (Ren et al., 1996; Colavita et
al., 1998; Suzuki et al., 1999).
BMP SIGNALING PATHWAY
BMPs are synthesized as large precursor proteins. Upon
dimerization, the molecules are proteolytically cleaved
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within the cell to yield carboxy-terminal mature proteins.
Once secreted, the BMP dimers initiate signaling by binding
cooperatively to both type I and type II serine/threonine
kinase receptors (Ducy and Karsenty, 2000; Miyazono et al.,
2000). The type II receptors are constitutively active ki-
nases, which transphosphorylate type I receptors upon
ligand binding. The type I receptors activate intracellular
substrates by phosphorylation, and thus determine the
specificity of intracellular signals (Fig. 1). In mammals, only
seven type I receptors and five type II receptors have been
identified thus far (reviewed in Kawabata et al., 1998;
Miyazono et al., 2000) (Table 1). Signals from the serine/
threonine kinase receptors may be transduced by various
proteins. Genetic studies using C. elegans and Drosophila
have resulted in the identification of these downstream
signaling mediators of the receptors for BMP-like ligands in
these organisms, which were called, respectively, sma (Sav-
age et al., 1996) and Mothers against dpp (Mad) (Sekelsky et
al., 1995). An increasing number of the vertebrate members
belonging to this protein family have subsequently been
identified and are denoted Smad, a fusion of sma and Mad
(reviewed in Derynck et al., 1998; Raftery and Sutherland,
1999; Kawabata et al., 1999). Eight Smads are known in
mammals and are classified into three groups based on
their structures and functions. Receptor-regulated Smads
(R-Smads) transiently associate with type I serine/threonine
kinase receptors and undergo direct phosphorylation.
Smad1, -5, and -8 are activated by BMPR-IA or BMPR-IB
(Hoodless et al., 1996; Nishimura et al., 1998; Kawai et al.,
2000), whereas Smad2 and -3 mediate TGF- signaling
(Macı´as-Silva et al., 1996; Zhang et al., 1996a). These
R-Smads associate with the common partner Smad (Co-
Smad or Smad4), and these heteromeric complexes translo-
cate to the nucleus, where they interact with other tran-
scription factors to regulate the transcription of target genes
(Fig. 1). Finally, Smad6 and Smad7 interfere with R-Smads
and Co-Smads and are called inhibitory Smads (I-Smads)
(Imamura et al., 1997; Casellas and Brivanlou, 1998). Be-
sides signal transduction through Smad molecules, other
pathways may also be involved in the generation of signals
by members of the TGF- superfamily, like MAP kinases,
which are activated by BMPs and TGF-s in certain cell
types, as reviewed in Mulder (2000).
FUNCTIONS OF BMPs
As previously mentioned, the first BMPs were originally
isolated by their ability to induce ectopic bone and cartilage
formation in vivo in muscle tissue or subcutaneous sites of
rodents (Urist, 1965). This unique bone-inductive activity
indicates that BMPs provide the primordial signals for
osteodifferentiation. It is known that BMP proteins initiate
the cascade of endochondral bone formation, where mesen-
chymal stem cells differentiate into chondrocytes which
lay down a cartilage structure that is reabsorbed and re-
placed by (reviewed in Reddi, 1994) bone tissue. BMPs also
act as local factors in the regulation of osteoblast differen-
tiation as demonstrated in previous experiments (Katagiri
et al., 1990, 1994; Yamaguchi et al., 1991; Sampath et al.,
1992; Gitelman et al., 1995; and others). However, BMP
expression studies, as well as the analysis of BMP mouse
models, have demonstrated a much broader range of bio-
logical activities of the different BMP family members on
various cell types, including monocytes, epithelial cells,
mesenchymal cells, and neuronal cells. BMPs regulate cell
proliferation and differentiation, chemotaxis and apoptosis,
and control fundamental roles such as left–right asymme-
try, neurogenesis, mesoderm patterning, and development
of a number of organs, such as kidney, gut, lung, teeth,
limb, amnion, and testis (reviewed in Hogan 1996a,b; Graff,
1997; Ebendal et al., 1998; Wozney, 1998). Several BMP
knockout experiments in mice have contributed to eluci-
date the role of BMPs at different stages of development.
BMP-2-deficient mice had amnion/chorion malformation
and defects in cardiac development, and died during embry-
onic development (Zhang et al., 1996b). A skeletal pheno-
type was seen in adult BMP-3/ mice. These mice demon-
strated an increased trabecular bone density of the
metaphysis of the femur, indicating that BMP-3, in contrast
to the other BMP family members, is a negative determi-
nant of bone density (Daluiski et al., 2001). A null mutation
of the BMP-4 gene in mice resulted in defects in the
extraembryonic and posterior/ventral mesoderm formation
and are also embryonic lethal (Winnier et al., 1995). The
recessive short ear (se/se) mice have mutations in the
BMP-5 gene and demonstrated abnormalities in the skull
and axial parts of the skeleton, and showed numerous tissue
abnormalities, affecting lung, liver, uterus, bladder, and
intestine. These BMP-5 null mice were viable and fertile
TABLE 1
Type I and Type II Serine/Threonine Kinase Receptors Involved
in the Signaling Pathway of TGF- Superfamily Members and
Their Ligands
Serine/threonine kinase receptor Ligand
Type I receptors or activin receptor-like
kinases (ALK)
ALK-1 BMPs
ALK-2 or ActR-I BMPs, Activin
ALK-3 or BMPR-IA BMPs
ALK-4 or ActR-IB TGF-, Activin
ALK-5 or TR-I TGF-, Activin
ALK-6 or BMPR-IB BMPs, AMH
ALK-7 ?
Type II receptors
Activin type II (ActR-II) Activin, BMPs
Activin type IIB (ActR-IIB) Activin, BMPs
TGF- type II receptor (TR-II) TGF-
BMP type II receptor (BMPR-II) BMPs
Anti-mullerian hormone type II
receptor (AMHR-II)
AMH
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(Green, 1958; Kingsley et al., 1992; King et al., 1994).
Targeted inactivation of BMP-6 in mice resulted in viable
and fertile mice, with no overt defects in tissues known to
express BMP-6; however, careful examination of skeleto-
genesis in late gestation embryos revealed a mild delay of
sternum ossification (Solloway et al., 1998). BMP-7 knock-
out mice were born alive with polydactyly of the inner digit
of the hindlimbs, and most of them died within 24 h after
birth. The mice showed skeletal defects, with a smaller
overall size compared with their normal littermates, and
suffered from defects in eye development. The kidney was
small and showed poor nephron development (Jena et al.,
1997). Mice with mutations in the GDF-5 gene, also known
as brachypodism (bp) mice, have short limbs, altered for-
mation of bones and joints in the sternum, and reduced
numbers of bones in the digits (Storm et al., 1994). Targeted
inactivation of BMP-8B, a gene present in mice but absent
in humans, resulted in abnormalities in spermatogenesis in
early puberty and in adulthood (Zhao et al., 1996).
MODULATION OF BMP SIGNALING
Finely tuned signals between cells are necessary to coor-
dinate all aspects of development, from patterning of the
embryonic body axis to homeostasis of adult tissues. For
this reason, BMP signaling is subjected to delicate regula-
tion at multiple levels: intracellularly, at the membrane
site, and extracellularly (Fig. 2). The first level of regulation
resides within the cell cytoplasm, where inhibitory Smads
and Smurfs act as modulators. Von Bubnoff and Cho (2001)
wrote a comprehensive review on this intracellular regula-
tion of BMP signaling in vertebrates. Recently, the trans-
membrane protein BAMBI (BMP and Activin membrane-
bound inhibitor), playing a role in attenuating BMP
signaling, was identified in Xenopus. BAMBI encodes a
TGF- pseudoreceptor, which stably associates with TGF-
-family receptors and interferes with BMP, Activin, and
TGF- signaling (Onichtchouck et al., 1999; Grotewold et
al., 2001). Finally, in the extracellular space, a control
FIG. 1. Cascade of BMP signaling. BMP dimers bind to serine/threonine kinase receptors type I and II. Upon ligand binding, type II
receptors transphosphorylate type I receptors. The latter phosphorylate members of the Smad family of transcription factors. These Smads
are subsequently translocated to the nucleus, where they activate transcription of target genes.
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system exists, whereby high affinity antagonists complex
selectively with BMPs to inhibit their biological activities.
Intracellular Modulation
Inhibitory Smads (I-Smads), i.e., Smad6 and Smad7, an-
tagonize the TGF- signaling pathway either by interacting
with phosphorylated type I receptors and thereby prevent-
ing the activation of R-Smads, or through competition with
Co-Smads for the formation of the R-Smad/Co-Smad com-
plexes (Itoh et al., 2001) (Fig. 2). The expression of Smad6
and Smad7 is induced by multiple stimuli, including epi-
dermal growth factor (EGF) and various TGF- family
members, such as TGF-1, Activin, and BMP-7, suggesting
the existence of a negative feedback signal (Nakao et al.,
1997). It has also been demonstrated that Smad6 and
Smad7 expression is regulated by pathological conditions,
such as laminar shear stress in vascular endothelial cells
(Topper et al., 1997).
Two closely related Smurfs (Smad ubiquitination regula-
tory factors), Smurf1 and Smurf2, have been identified in
vertebrates and are mediators of the final step in ubiquiti-
nation of target proteins (Zhu et al., 1999a, 2001). This
family of enzymes, which contains HECT catalytic do-
mains characteristic of E3-ubiquitin ligases, modulate
TGF- signaling by selectively targeting the activated type
I receptors (Kavsak et al., 2000; Ebisawa et al., 2001) and
Smad proteins (Lo and Massague´ 1999; Lin et al., 2000;
Zhang et al., 2001) for degradation (Fig. 2).
Membrane Receptor Modulation
Xenopus BAMBI is a pseudoreceptor for members of the
TGF- superfamily showing high sequence similarity to
Nma, its mammalian homologue. BAMBI/Nma is structur-
ally related to type I serine/threonine kinase receptors in
the extracellular domain, but it lacks the intracellular
serine/threonine kinase domain (Onichtchouck et al., 1999;
FIG. 2. Three levels of modulation of BMP signaling. (1) I-Smads and Smurfs regulate intracellular signaling by preventing further Smad
signaling and consequent activation of gene transcription, (2) Pseudoreceptor BAMBI/Nma modulates BMP signaling at the membrane site
by binding to BMP type II receptors, and (3) Extracellular antagonists modulate binding of BMP dimers to the BMP type I and type II
receptors.
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Grotewold et al., 2001). The pseudoreceptor antagonizes
the effects of TGF-, Activin, and BMPs by stably associat-
ing with serine/threonine kinase receptors, thus preventing
the formation of active receptor complexes (Onichtchouck
et al., 1999) (Fig. 2).
Extracellular Modulation
The exact concentration of active TGF-s seems to be
important for rendering a particular biological effect. It was
found in Xenopus and Drosophila that an activity gradient
of the members of the BMP family of growth factors is
formed during embryogenesis, leading to the generation of
different cell types, depending on the location (Wharton et
al., 1993; Dale and Wardle, 1999; Dale and Jones, 1999; De
Robertis et al., 2000). The active local concentration and
consequently the extent of action of these morphogens is
controlled, in part, by the influence of extracellular modu-
lators (Barth et al., 1999; Liem et al., 2000; Hama and
Weinstein, 2001) (Fig. 2). An increasing number of these
natural antagonists is being identified in vertebrates and
invertebrates, and appears to have evolved independently
due to lack of primary sequence conservation. In verte-
brates, the list of BMP antagonists already comprises more
than seven proteins, including noggin, chordin, chordin-
like, follistatin, FSRP, the DAN/Cerberus protein family,
and sclerostin. Studies in Drosophila demonstrated the
presence of similar antagonists in invertebrates. The Dro-
sophila short gastrulation (sog) is the homologue of chordin,
and affects dorsal–ventral patterning by antagonizing dpp
and screw, the homologues of, respectively, vertebrate
BMP-2/-4 and BMP-5/-6/-7/-8 (Holley et al., 1995; Neul and
Ferguson, 1998). In both vertebrates and invertebrates,
other regulating factors are involved in the BMP/dpp-screw
pathway. Secreted zinc metalloproteinases antagonize the
activity of chordin/sog, including Drosophila Tolloid (Tld),
Xenopus Xolloid (Xol), and human BMP-1 (Marques et al.,
1997). Another extracellular factor, twisted gastrulation
(tsg), which is conserved among vertebrate and invertebrate
species, influences this proteinase cleavage and modifies
the interactions between chordin/sog and BMP/dpp-screw
by binding to the complex. The formation of this ternary
complex leads to a more efficient inhibition of BMP/dpp
activity (Oelgeschla¨ger et al., 2000). The goal of this review
is to focus on the group of the vertebrate extracellular BMP
antagonists.
REGULATION OF BMP SIGNALING IN
VERTEBRATES THROUGH
EXTRACELLULAR MODULATORS
Noggin
Noggin was first isolated from X. laevis based upon its
ability to rescue dorsal development in embryos ventralized
by UV treatment (Smith and Harland, 1992) and is ex-
pressed during early stages of gastrulation in the Spemann
organizer, a tissue which plays a central role in specifying
dorsal cell fates in both ectoderm (neural plate) and meso-
derm (somite and notochord), where it promotes the devel-
opment of dorsal tissues, such as muscle and nervous tissue
(McMahon et al., 1998).
In the zebrafish embryo, three noggin orthologues have
been isolated, noggin1, noggin2, and noggin3, with noggin1
and noggin3 being highly related to the noggins of higher
vertebrates and noggin2 being somewhat more divergent.
Noggin1 is expressed in the organizing center of the ze-
brafish, while noggin2 transcripts first appear at the end of
gastrulation. Both genes are expressed during somitogenesis
and during formation of the nervous system. Noggin1 and
noggin2 overexpression strongly dorsalizes the embryo,
suggesting a role in dorsoventral patterning of the zebrafish
(Bauer et al., 1998). Noggin expression is limited to late
stages of embryonic development and is restricted to re-
gions of ongoing chondrogenesis (Fu¨rthauer et al., 1999).
During the early stages of mouse embryonic develop-
ment, noggin is expressed in the node, a structure with
similar properties to the Xenopus organizer. However,
knockout experiments in mice failed to show the require-
ment of noggin in the formation of neural tissue, notochord,
or somites during the early gastrulation stages (McMahon
et al., 1998). Bachiller et al. (2000) were able to demonstrate
in noggin/chordin double knockout mice, that, in these
early stages of development, the loss of noggin function
could be rescued by chordin, another BMP antagonist. They
showed an overlap in expression of both genes at the
midgastrula stage. Absence of both noggin and chordin
expression led to inappropriate anteroposterior, dorsoven-
tral, and left–right patterning (Table 2). Later on in mouse
embryonic development, noggin expression was seen in the
notochord, the roof of the neural tube, the dorsal aspect of
the somites, and the limbs. Loss of noggin expression in
these later sites has profound effects on development and
results in a recessive lethal phenotype at birth. Noggin
knockout mice are characterized by numerous defects: a
shortened body axis caudal to the forelimbs with reduced
size of the somites and neural tube, an open neural tube of
varying severity, loss of caudal vertebra, and malformed
limbs (McMahon et al., 1998) (Table 2). Brunet et al. (1998)
studied the same noggin knockout mouse model and
showed that expression of the mouse noggin gene is essen-
tial for proper skeletal development. In these homozygous
mutant mice, vertebra, ribs, and limbs were all affected.
Examination revealed excess bone and cartilage and failure
to initiate joint formation due to excess of BMP activity
(Table 2). Absence of noggin in these mutant mice and the
consequent absence of regulating BMP activity probably
lead to failure of activating the GDF-5 gene, necessary to
initiate joint development. Noggin has been proposed as an
upstream modulator of GDF-5 signaling, which is consis-
tent with the similar pattern of joints affected in noggin and
GDF-5 (brachypodism, bp) null mice (Storm et al., 1994;
Storm and Kingsley, 1996; McMahon et al., 1998; Brunet et
al., 1998). Kulessa et al. (2000) used transgenic mice over-
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expressing noggin under control of the mouse Msx2 pro-
moter to demonstrate the involvement of noggin in postna-
tal hair development. These mice form hair follicles but
lack external hairs, due to impaired differentiation of shaft
hair cells. Additionally, these mice display mild limb ab-
normalities (Table 2).
Noggin is known to bind and antagonize BMP-2, -4, and
-7, with a higher affinity for BMP-2 and -4 (Zimmerman et
al., 1996). Studies demonstrated that noggin inhibits BMP-4
activity in a competitive manner by binding to BMP-4 and
consequently interfering with the ability of BMP-4 to bind
to cognate cell-surface receptors (Zimmerman et al., 1996).
Additionally, noggin has been shown to interact directly
with GDF-5 in vitro and influences its effect in vivo.
Merino et al. (1999a) suggested a possible antagonistic role
for noggin in regulating the signaling of GDF-5 during digit
skeletogenesis in the embryonic chick bud (Table 3).
The noggin gene, encoding a secreted protein of 232
amino acids, was mapped to human chromosome 17q22
(Valenzuela et al., 1995), in the region where both proximal
symphalangism (SYM1; MIM185800) (Polymeropoulos et
al., 1995) and multiple synostoses syndrome (SYNS;
MIM186500) (Krakow et al., 1998) are located. Both condi-
tions are characterized by multiple joint fusions. Evidence
was provided that noggin is associated with joint and
vertebra formation in humans by the identification of
TABLE 2
Mouse Models Involving the Different BMP Antagonists
Model Type Phenotypical abnormalities Reference
Noggin/ knockout lethal phenotype
shortened body axis
reduced size of somites and neural tube
loss of caudal vertebra
malformed limbs
excess bone and cartilage
failure to initiate joint formation
McMahon et al.
(1998); Brunet et
al. (1998)
Noggin Transgenic (Msx2
promoter)
defects in postnatal hair development
limb abnormalities
Kulessa et al. (2000)
Chordin/ knockout stillborn animals
defects in inner and outer ear development
abnormalities in pharyngeal and cardiovascular
organization
Bachiller et al. (2000)
Chordin-like — — —
Noggin//Chordin/ knockout defects in antero-posterior, dorso-ventral and left-
right patterning
Bachiller et al. (2000)
Follistatin/ knockout lethal phenotype
reduced size
skeletal abnormalities
defects in whisker and tooth development
shiny, taut skin
Matzuk et al. (1995)
Follistatin Transgenic
(MT-I promoter)
reduced fertility
smaller testis in males
smaller ovaries and thinner uteri in females
minor defects in hair formation
Guo et al. (1997)
FSRP Transgenic
(MT-I promoter)
Severly impaired fertility Schneyer et al. (2001)
Dan/ knockout No obvious phenotypical abnormalities Dionne et al. (2001)
Dan//Noggin/ knockout transformation of last lumbar vertebrae to sacral fate Dionne et al. (2001)
Cerberus/ knockout no obvious phenotypical abnormalities Simpson et al. (1999)
Cerberus/ knockout no obvious phenotypical abnormalities Belo et al. (2000)
Cerberus/ knockout no obvious phenotypical abnormalities Shawlot et al. (2000)
CerberuslacZ/lacZ knockout no obvious phenotypical abnormalities Stanley et al. (2000)
Cerberus//Noggin/ knockout only defects due to lack of noggin Borges et al. (2001)
Gremlin — — —
Dante — — —
PRDC — — —
Sclerostin — — —
Sclerostin-like — — —
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disease-causing mutations in five unrelated families with
SYM1, a mutation in an isolated patient with SYM1 and
one mutation was detected in a family with SYNS (Gong et
al., 1999). Noggin is also involved in Fybrodysplasia Ossifi-
cans Progressiva (FOP; MIM135100), a rare genetic disorder
characterized by congenital malformation of the great toes
and progressive heterotropic endochondral ossification of
the muscles (Connor and Evans, 1982). A genome-wide
linkage search localized the FOP gene to the human chro-
mosome 17q21-q22 region, close to noggin (Lucotte et al.,
2000). Initially, a 42-bp deletion was found in one FOP
patient (Lucotte et al., 1999), and recently, three different
missense mutations in noggin were detected in three Span-
ish families with FOP (Semonin et al., 2001). It has also
been demonstrated that missense mutations in noggin
cause tarsal/carpal coalition syndrome (TCC; MIM186400),
a condition characterized by multiple carpal and tarsal
synostosis, as well as radial-head distortion, aplasia, or
hypoplasia of the middle phalanges, and metacarpophalan-
geal synostosis (Dixon et al., 2001) (Table 4).
Chordin and Chordin-Like
Like noggin, chordin plays major roles in dorsoventral
axis formation and in the induction, maintenance, and/or
differentiation of neural tissues during gastrulation, and is
secreted by the Spemann organizer of Xenopus and ze-
brafish, and by the node of chick and mouse embryos (Streit
et al., 1998; Sasai et al., 1994; Miller-Bertoglio et al., 1997).
When chordin is secreted from the organizer, it acts by
interfering in BMP signaling, allowing dorsally derived
tissues, such as neurectoderm and somitic muscle, to
develop (Miller-Bertoglio et al., 1997). Genetic data, which
support and extend the findings in Xenopus, have been
obtained in zebrafish, where as a null mutation in the
zebrafish chordin, designated chordino, showed a ventral-
ized phenotype (Schulte-Merker et al., 1997).
Chordin expression in the mouse is seen in most major
organs, like brain, lung, liver, and kidney, suggesting mul-
tiple functions in organogenesis. Chordin expression is
relatively high in condensing and differentiating cartilage
elements, where it is coexpressed with BMP-2, -4, and –7,
indicating an important role in embryonic skeletogenesis
(Scott et al., 2000). Fisher and Halpern (1999) already
provided evidence that chordin plays an important role in
patterning of the axial skeleton in zebrafish. Targeted
inactivation of chordin in mice resulted in stillborn ani-
mals, which have normal early development and neural
induction, but at later stages of embryogenesis, they
showed defects in inner and outer ear development and
abnormalities in pharyngeal and cardiovascular organiza-
tion (Bachiller et al., 2000) (Table 2).
Chordin binds BMP-2, -4, and -7 in a way similar to
noggin, with a higher affinity for BMP-2 and –4, and
antagonizes BMP signaling by blocking the binding to the
BMP receptors (Piccolo et al., 1996) (Table 3).
Radiation hybrid mapping localized the human chordin
gene to chromosome 3q27 (Pappano et al., 1998). The gene
encodes a protein of 955 amino acids, containing a signal
peptide for secretion and four cysteine-rich (CR) domains.
Recently, three alternatively spliced, human chordin vari-
ants have been described, carrying at least part of one of the
four CR domains, and showing biological activities (Millet
et al., 2001) (Table 4). These results suggested a possible
influence of these variants on BMP activity in different
developmental situations. Chordin has been considered a
candidate gene for Cornelia de Lange syndrome (CDLS;
MIM122470), a condition characterized by typical facies in
association with prenatal and postnatal growth retardation,
mental retardation, and upper limb anomalies (de Lange,
1933). The CDLS gene was previously mapped to this
chromosomal 3q27 region, but mutation analysis in pa-
tients with CDLS failed to reveal disease-causing mutations
(Smith et al., 1999).
Nakayama et al. (2001) isolated from mouse bone marrow
stromal cells the chordin-like protein (CHL), which showed
TABLE 3
Ligands for the Different BMP Antagonists
Comments BMP-2 BMP-4 BMP-5 BMP-6 BMP-7 GDF-5 GDF-11 Activin Nodal Wnt
Noggin    
Chordin   
Chordin-like   
Follistatin     
FSRP    
DAN    
Cerberus      
Gremlin   
Dante Unknown
PRDC Unknown
Sclerostin  
Sclerostin-like Unknown
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significant homology to chordin and interacts in vitro with
BMP-4, -5, and –6. As a result of alternative splicing and
alternative transcriptional termination, four forms of CHL
exist in mouse and human, the short forms mCHL(s1) and
mCHL(s2), and the long forms mCHL(l1) and mCHL(l2) in
mice, and four long forms, CHL(l1)–CHL(l4), in humans.
Coffinier et al. (2001) isolated a chordin-related molecule,
called neuralin-1, which, based on amino acid sequence
comparison, showed 100% homology with CHL, indicating
that both groups isolated an identical protein. Additionally,
another group isolated from chick retina a protein called
ventroptin with a possible function in the determination of
dorsal–ventral cell fates in the retina by antagonizing
BMP-4 (Sakuta et al., 2001). Amino acid sequence analysis
provided evidence that this novel protein is identical with
CHL. CHL (or neuralin-1 or ventroptin) is expressed prefer-
entially in mesenchymal cell lines, and the spatiotemporal
expression in mice differs from that of chordin, suggesting
that both proteins would have different and/or nonoverlap-
ping biological roles. During mouse embryogenesis, CHL
expression was first detected in the somites and neural
plate, the dermatome, and limb bud mesenchymes. High
expression levels were seen in the developing skeletal
structures, including limb bones, clavicles, calvaria, verte-
bra, and ribs. In the adult mouse, CHL is expressed in brain,
lung, kidney, and testis. Expression of CHL in nonskeletal
mesenchymal cells was demonstrated in many adult con-
nective tissue cell types (Nakayama et al., 2001).
Follistatin and FSRP
Follistatin was originally isolated from ovarian fluid by
virtue of its ability to suppress follicle-stimulating hor-
mone (FSH) secretion from the pituitary. The follistatin
protein has been isolated on the basis of its involvement
during the reproductive cycle and is expressed in a wide
range of embryonic and adult tissues, including brain,
testis, ovary, bone marrow, placenta, and the anterior
pituitary (reviewed in Patel, 1998).
Expression patterns of follistatin in the organizer of the
blastopore in Xenopus embryos at the onset of gastrulation
suggest that this gene might have a dorsal function in
Xenopus embryos, in addition to its role as a neural inducer
(Hemmati-Brivanlou et al., 1994; Fainsod et al., 1997).
Follistatin knockout mice display a number of defects.
They are smaller than their heterozygous littermates and
they present with less muscle. The mice fail to breathe and
die soon after birth. They also display certain skeletal
abnormalities as well as improper tooth and whisker devel-
opment, and their skin is taut and shiny (Matzuk et al.,
1995). Transgenic mice overexpressing follistatin, under
control of the mouse metallothionein (MT)-I promoter,
were not lethal and were of normal size, but had shiny
irregular fur. Fertility was reduced: males had smaller testis
whereas females had smaller ovaries and thinner uteri,
clearly indicating a key role for follistatin during sexual
development (Guo et al., 1998) (Table 2).
TABLE 4
Number of Amino Acids, Chromosomal Localization, and Associated Disease, and Also Alternative Names for the Different Human
BMP Antagonists
Protein Alternative names Amino acids Chromosome Associated disease
Noggin 232 17q22 Proximal symphalangism
Multiple synostoses syndrome1
Fybrodysplasia ossificans progressiva
Tarsal/carpal coalition syndrome
Chordin 955 3q27 —
86 (variant 1)
94 (variant 2)
350 (variant 3)
Chordin-like Neuralin-1 (mouse) CHL(11) 452 Xq22.1-q23 —
Ventroptin (chick) CHL(12) 451
CHL(13) 447
CHL(14) 446
Follistatin 344 5q11.2 —
FSRP 263 19p13 —
DAN 180 1p36.13-p36.11 —
Cerberus CER1 Caronte (chick) 267 9p22 —
Gremlin 184 15q13-q15 —
Dante 80 ? —
PRDC 168 1q42-q43 —
sclerostin 213 17q12-q21 Sclerosteosis
van Buchem disease
Sclerostin-like 206 7p21 —
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Follistatin was identified as an Activin-binding protein
that prevents Activin from binding to its receptor (Naka-
mura et al., 1990; Hemmati-Brivanlou et al., 1994). It has
also been shown that follistatin binds BMP-2, -4, and -7,
with higher affinities for BMP-7 (Yamashita et al., 1995;
Iemura et al., 1998), although the affinity of follistatin for
BMPs is lower than that of follistatin for Activin (Naka-
mura et al., 1990; Iemura et al., 1998). Iemura et al. (1998)
demonstrated that follistatin can inhibit the effect of
BMP-2, -4, and –7 in a manner different from that of the
other organizer factors, noggin and chordin, by binding to
BMP receptors through BMPs, forming a trimeric complex.
Recently, Gamer et al. (2001) demonstrated antagonistic
action of follistatin for GDF-11, a key regulator of pattern-
ing the axial skeleton in chick limb buds (Table 3).
Activin signaling has been implicated in early limb
development (Stern et al., 1995) and in skeletal muscle
differentiation (Link and Nishi, 1997), and probably also in
limb skeletogenesis. Merino et al. (1999a) proved involve-
ment of Activin in the control of digit formation. Follistatin
expression followed the same temporal and spatial pattern
as digit formation, and was coexpressed with Activin at the
distal growing tip of the digits, suggesting a molecular
coordination of Activin signaling, and thus digit formation,
by follistatin.
Using FISH techniques, Bondestam et al. (1999) localized
the human follistatin gene to the chromosomal 5q11.2
region. Structurally, follistatin is composed of a signal
peptide for secretion, followed by the NH2-terminal domain
and three follistatin domains (FS domains), which consist of
70 amino acids with 10 conserved cysteine residues
(Hemmati-Brivanlou et al., 1994). Shimasaki et al. (1988)
isolated two forms of follistatin cDNA which differed in
the 3 region of the open reading frames as a result of
alternative splicing of the precursor mRNA. One form
encodes a protein of 317 amino acids, while the other form
encodes a protein of 344 amino acids, having the same 317
amino acids as the first form but with an additional 27
amino acids at the COOH-terminal side (Table 4). By using
linkage and association studies, evidence was provided that
the follistatin gene was linked with the polycystic ovary
syndrome (PCOS; MIM184700), a common endocrine dis-
order in women, characterized by hyperandrogenism and
chronic anovulation leading to female infertility (Urbanek
et al., 1999). However, mutation analysis in 34 women
diagnosed with PCOS did not result in the identification of
disease-causing mutations in the coding sequence of the
follistatin gene (Calvo et al., 2001) (Table 4).
A number of proteins have been described showing
homology to follistatin. Based on their structure, these
proteins could be classified in two subfamilies. The first
group is the follistatin-related genes (FLRG), like agrin,
testican, SPARC, and Flik, which share only one FS domain
and do not demonstrate any Activin-binding activity. Flik
(follistatin-like) was first isolated from a mouse osteoblastic
cell line as a TGF-1-inducible protein (called TSC-36)
(Shibanuma et al., 1993), and rat and human homologues
were cloned from glioma cell lines (Zwijsen et al., 1994).
Studies of the chick Flik gene in early embryonic develop-
ment demonstrated an expression pattern which overlaps
with follistatin (Patel et al., 1996). From studies in Xenopus,
follistatin showed a neural-inducing activity (Hemmati-
Brivanlou et al., 1994), although follistatin null mutant
mice did not show any inhibition of neural induction. The
loss of follistatin could be compensated noggin and chordin
or by a protein structurally related to follistatin. Flik was
found to be expressed in the ectoderm at the time of
neurulation and might therefore be a functional equivalent
of follistatin and be able to compensate loss of follistatin
function in neural induction. Functional studies need to be
carried out to verify this hypothesis. The second group of
follistatin structural homologues contains at this moment
only one protein, which was called follistatin-related pro-
tein (FSRP). Hayette et al. (1998) first reported the cloning
of the mouse and human homologues. Both mouse and
human FSRP contain two FS domains, and comparison of
the gene structure and overall primary sequence homology
between FSRP and follistatin clearly showed a much greater
homology than the other FS domain-containing proteins.
Schneyer et al. (2001) and Tortoriello et al. (2001) were able
to demonstrate that FSRP binds to Activin and BMPs in a
way similar to follistatin. Despite the structural homology
between follistatin and FSRP, both proteins are thought to
have distinct biological functions (Schneyer et al., 2001;
Tortoriello et al., 2001). Preliminary results from FSRP
transgenic mice showed severely impaired fertility relative
to control mice (Schneyer et al., 2001).
DAN/Cerberus Protein Family
Recently, a novel family of secreted proteins with antago-
nistic activities against BMPs was identified, sharing a
similar structural motif and similar but nonidentical induc-
tive activities (Hsu et al., 1998; Pearce et al., 1999). The
domain of homology in proteins from this family was
called the “can-domain,” containing the consensus se-
quence CX6QX6CX6NX2CXGXCXSX3PX(8–13)CX2CXPX8XL-
XCX(15–18)CXX (Pearce et al., 1999) (Fig. 3A). Outside this
domain, the family members showed little similarity. The
domain is related to domains seen in the mucins and the
Norrie disease protein (NDP) (Biben et al., 1998) (Fig. 3B)
and is structurally related to the cysteine-knot motif of the
TGF- superfamily, with an additional conservation of six
amino acid residues (Fig. 3A). Initially, this family con-
tained three proteins: DAN, cerberus, and gremlin, but
recently, other proteins were isolated which could be clas-
sified as a member of this family: Dte, protein related to
DAN and cerberus (PRDC), and also several genes identified
as expressed sequence tags in the mouse. Until present,
little was known about either the specificity of these
antagonists or the biological roles of these proteins. Using
Xenopus explant assays, Hsu et al. (1998) showed that at
least DAN, cerberus, and gremlin act as BMP antagonists,
presumably in a way similar to noggin and chordin, by
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direct physical binding to BMP molecules and consequently
blocking the specific ligand/receptor interactions.
DAN. DAN was originally cloned as a transcript down-
regulated in src-transformed rat fibroblasts and was called
“differential screening-selected gene aberrant in neuroblas-
toma” (Ozaki and Sakiyama, 1993). The expression of DAN
was found to be significantly reduced in a variety of
transformed cells and showed homology to a mouse sup-
pressor gene (Enomoto et al., 1994).
Hsu et al. (1998) demonstrated the involvement of DAN
in axial patterning activities with the ability to dorsalize
ventral mesoderm and neuralize ectoderm in Xenopus in-
jection studies, which implies a role for DAN in early
gastrulation stages.
During mouse embryogenesis, DAN was expressed in
cranial mesenchyme and somites, later in limb and facial
mesenchyme. DAN was also expressed in the developing
myotome (Stanley et al., 1998; Eimon and Harland, 2001).
These expression domains include sites in which BMP
inhibition is known to be important for development. DAN
expression was seen in virtually all adult tissues, including
lung, kidney, brain, intestine, stomach, and spleen. The
expression profiles suggest that DAN is a modulator of
inductive processes and cell growth during embryonic as
well as adult life.
DAN knockout mice were viable, fertile, and did not
show any obvious morphological abnormalities in the head
mesoderm, somites, facial structures, and limbs during
early mouse embryogenesis, nor did these mice show any
defects during neural tube development. Skeletal develop-
ment was also not impaired (Dionne et al., 2001) (Table 2).
DAN null mutant mice which were heterozygous for nog-
gin displayed, at low penetrance, an apparent transforma-
tion on the right-hand side of the last lumbar vertebrae to a
sacral fate. This finding suggests that DAN and noggin may
be involved in region-specific regulation of BMP and GDF
signals in order to properly regulate anterior–posterior iden-
tity in the posterior lumbar region (Dionne et al., 2001)
(Table 2).
DAN has been shown to bind BMP-2 in vitro (Hsu et al.,
1998); however, interaction between DAN and any specific
TGF- family member under physiological conditions re-
mains to be demonstrated. Dionne et al. (2001) showed that
it is unlikely that BMP-2, -4, and -7 are physiological targets
for DAN, although overexpressing these BMPs in Xenopus
embryos did show interaction with DAN. However, they
could demonstrate interaction of DAN with GDF-5, an-
other member of the BMP-family and closely related to
BMP-2, -4, and –7 (Table 3).
The DAN gene, encoding a secreted protein of 180 amino
acids, was mapped to human chromosome 1p36.13-p36.11,
in a region known to be involved in genesis/progression of
human neuroblastoma (Enomoto et al., 1994) and was
considered as a possible candidate for a tumor suppressor
gene of human neuroblastoma. However, loss of heterozy-
gosity (LOH) studies excluded DAN as a candidate gene
(White et al., 1995) (Table 4).
Cerberus. Cerberus is a secreted growth factor ex-
pressed in the Spemann organizer and anterior endomeso-
derm of gastrula-stage embryos. Whereas noggin, chordin,
follistatin, and DAN are able to induce neural tissue devel-
opment and axis formation when mRNA is injected into
Xenopus embryos, Cerberus suppresses the formation of
posterior mesoderm and specifically induces formation of
ectopic head structures, such as cement gland, olfactory
placodes, eyes, and forebrain (Bouwmeester et al., 1996).
Biben et al. (1998) suggested that Xenopus Cerberus (xCer),
which showed BMP-4, Nodal, and Wnt antagonistic activi-
ties, might participate directly or indirectly in freeing the
prospective head region from the influence of these ventral-
FIG. 3. (A) Alignment of the murine amino acid sequence within the “can-domain” of the different members of the DAN/Cerberus
protein family. Conservation of six cysteine and one glycine residues essential for the formation of the core cysteine knot is represented
by blue and green bars, respectively. Six additional amino acid residues (Q, N, S, P, P, L) conserved and typical for the can-domain are
numbered 1–6. Three additional conserved cysteine residues are numbered A–C. (B) Alignment of murine sclerostin, sclerostin-like, MUC2,
NDP, and murine members of the CCN-gene family (NOV), the gonadotropins (TSH-B), and the BMP-family (BMP-4 and BMP-7) to the
can-domain.
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izing growth factors, a theory which has been confirmed by
Piccolo et al. (1999). Additionally, xCer was able to antago-
nize the activity of the mesoderm-inducing Activin ligands
(Hsu et al., 1998) (Table 3).
Shawlot et al. (1998) described a mouse homologue of
xCer and called this gene mouse cerberus-related gene
mCer1, also known as Cerr1, cer-l, Cer1, with the mCer1
protein sharing 57% similarity to xCer in the C-terminal
cysteine-knot region. Although the expression patterns of
xCer and mCer1 overlap in early embryogenesis (Belo et al.,
1997; Biben et al., 1998), it is still unclear whether mCer1 is
the mouse homologue of xCer or only a Cerberus gene
family member. During early mouse embryogenesis, mCer1
is expressed in the anterior visceral and definitive meso-
derm and in the forming somitic mesoderm (Shawlot et al.,
1998), suggesting a role in development of the axial skel-
eton, musculature, and peripheral nervous system. The
neural-inducing and mesoderm-inhibiting activities of
mCer in mice result from specific binding to BMP and
Nodal proteins, respectively. However, in contrast with
xCer, no direct inhibition of Wnt signals was detected (Belo
et al., 2000). Thus far, evidence for binding of mCer to
Activin has also not been provided. No expression of mCer1
was detected in adult tissues, such as brain, skeletal
muscle, heart, lung, stomach, spleen, liver, kidney, uterus,
testis, and ovary (Biben et al., 1998). Simpson et al. (1999)
studied an inbred mouse strain carrying a chromosomal
deletion encompassing mCer1, which was called Tyrp1b-464THC.
mCer1-deleted mouse embryos have grossly normal morphol-
ogy, and in particular they had developed normal head struc-
tures. Anterior patterning and somite formation was not
disrupted. These results demonstrated that mCer1 is not
required for normal morphological development of the mouse
embryo and they suggest that other proteins with overlapping
functions may be capable of compensating mCer1 function
(Table 2). Furthermore, Belo et al. (2000) generated a mCer1
null allele by targeted inactivation in ES cells. The homozy-
gous knockout mice showed no anterior patterning defects,
are born alive, and are fertile (Table 2). Shawlot et al. (2000)
also generated mCer1-deficient mice by targeted inactivation
in ES cells. Comparison with wild type embryos revealed no
obvious defects in head formation in mCer1/ embryos, and
also heart development and somite formation appeared nor-
mal. At later stages of embryonic development, the null mice
appeared phenotypically identical to their normal littermates.
Skeletal development was also normal in newborn mCer1/
mice (Table 2). Stanley et al. (2000) generated mCer1 null
mice by targeted insertion of a lacZ reporter gene in the mCer
locus, which allowed them to study mCer1 expression pat-
terns during embryonic and adult development. Besides pre-
viously reported expression profiles of mCer1 at sites of
embryonic development (Shawlot et al., 1998; Biben et al.,
1998), they showed the presence of mCer1 in the developing
lung, pancreas, hair follicles, and nervous system. In the
developing skeleton, mCer1 was seen in areas of new cartilage
formation, in the developing ear, presumptive limb joints,
vertebra, and ribs. Postnatally, expression was associated with
numerous structures around the joint. Development at these
sites of mCer1 expression appeared normal in mCer1lacZ/lacZ
mutants (Table 2). Results from expression studies within
these four knockout mice models suggested that mCer is not
essential in mouse development and that mCer1 function
might be compensated by another molecule. Borges et al.
(2001) studied a mCer1//noggin/ double knockout mouse
model to check possible compensation, but failed to show any
additional detectable defects besides the ones presented by the
noggin/ single mutants (Table 2).
Expression of Cerberus in the chick (cCer) showed an
overlapping expression pattern with Nodal, a gene involved
in left–right asymmetry of the embryonic head (Zhu et al.,
1999b). cCer was found to be restricted to the left lateral
plate mesoderm and head mesenchyme. The left-sided
expression of cCer was found to be regulated by Sonic
Hedgehog (Shh), both in the head and trunk; expression of
the left side in the head, but not in the trunk, was also
controlled by Nodal (Zhu et al., 1999b; King and Brown,
1999). Yokouchi et al. (1999) isolated a novel cerberus-
related gene, called Caronte, from the chick, which showed
antagonistic activities against BMP-2, -4, and -7, Activin,
and Nodal, and with asymmetrical expression in the left
paraxial mesoderm. Caronte is induced by Shh and re-
pressed by FGF8, and plays a role in Nodal signaling.
Functional and expression analyses of Caronte showed
identical patterns with cCer and sequence comparison of
the two proteins showed complete homology, indicating
that both proteins are the same.
The human Cerberus gene (CER1) was isolated by library
screening and localized by radiation hybrid mapping to
chromosome 9p22 (Lah et al., 1999). The CER1 protein
contains 267 amino acids with a signal peptide for secre-
tion. Thus far, no disease phenotype is associated with
mutations in the CER1 gene (Table 4).
Gremlin. Using a differential expression assay, Topol et
al. (1997) isolated gremlin or drm (down-regulated in mos-
transformed cells), showing potential roles in cell growth
and tissue-specific differentiation. Expression of gremlin
could not be detected in a vast majority of malignant cell
lines, supporting the hypothesis that gremlin might play an
important role in carcinogenesis, functioning as an inhibi-
tor of tumor progression.
Hsu et al. (1998) identified Xenopus gremlin after a screen
for molecules capable of inducing a secondary axis in the
Xenopus embryo. Gremlin is not expressed during early
gastrulation of Xenopus embryos, despite axial patterning
activities, suggesting that its contribution to pattern forma-
tion will be in later steps. Instead, expression begins at
tailbud stages, where it is correlated with neural crest
lineages. Later on in development, gremlin expression is
extended rostrally and caudally to include neural crest cells
at all axial levels, suggesting a role in neural crest induction
and patterning.
Expression of gremlin during mouse embryogenesis starts
at the somite stage and the anterior ventral forebrain in the
neural tube. Later on, gremlin was observed in the dorsal
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and ventral mesenchyme of the limb buds, first in the
dorsal proximal domain and later in the proximal interdigi-
tal regions (Pearce et al., 1999).
By comparing gremlin expression patterns in chick em-
bryos with those seen in Xenopus (Hsu et al., 1998) and
mouse (Pearce et al., 1999), significant differences were
observed. In the chick, gremlin transcripts were detected in
the limb buds, the central part of branchial arches I, II, and
III, with strong expression in the mandibular and maxillar
processes of brancial arch I. Later on in chick development,
some expression was seen on both sides of the neural tube
in the trunk region, corresponding to the caudal part of each
myotome. Finally, gremlin expression was found in the
lateral part of the dermatome (Bardot et al., 2001).
Gremlin plays a role as mediator during vertebrate limb
outgrowth, in both mouse (Zuniga et al., 1999) and avian
(Merino et al., 1999b), where it is coexpressed with BMP-2,
-4, and -7, secreted factors known to play important roles in
limb development. Outgrowth and patterning of the verte-
brate limb are controlled by reciprocal interactions between
the posterior mesenchyme (polarizing region) and a special-
ized ectodermal structure, the apical ectodermal ridge
(AER). Sonic hedgehog (Shh) and fibroblast growth factors
(FGFs) are key signaling molecules produced in the polariz-
ing region and AER, respectively. Shh signaling by the
polarizing region modulates FGF signaling by the AER,
which in turn mediates the polarizing region (Shh/FGF4
feedback loop). By antagonizing BMP repression of FGF
activity, gremlin regulates this Shh/FGF4 feedback loop
(Zuniga et al., 1999). The ability of gremlin to bind and
block BMP-2, -4, and -7 activity has been demonstrated
both in vivo and in vitro (Hsu et al., 1998; Merino et al.,
1999b) (Table 3).
Gremlin is not only involved during early embryogenesis,
expression is also highly regulated in various adult rat
tissues, with high levels of expression in brain, spleen,
kidney, and testis, and it is particularly expressed in termi-
nally differentiated cells, suggesting specific roles and func-
tional mechanisms in adult tissues (Topol et al., 1997,
2000a).
Radiation hybrid mapping was used to localize the hu-
man gremlin gene to chromosome 15q13-q15, in a region
where association with human malignancies has been re-
ported (Topol et al., 2000b). The human gremlin cDNA
encodes a predicted protein of 184 amino acids containing a
signal peptide for secretion (Table 4). Bacchelli et al. (2001)
suggested that gremlin might be mutated in patients with
the autosomal recessive Cenani-Lenz syndrome (CLS;
MIM212780). The limb abnormalities in CLS closely re-
semble the ones found in a recessive mouse mutant, limb
deformity (ld), mutated in the formin gene (Woychik et al.,
1990; Mass et al., 1990). Gremlin is a downstream target of
formin and its expression is known to be lost in ld mice
(Zuniga et al., 1999). However, haplotype analysis in one
CLS patient with consanguineous parents using genetic
markers derived from the chromosome 15q13-q15 region
excluded gremlin as a candidate gene for CLS (Bacchelli et
al., 2001).
Dante. Based on structural homology, Pearce et al.
(1999) identified Dante (Dte), a novel DAN/Cerberus family
member in the mouse. However, screening assays for full-
length Dte cDNA has not yet been successful. The amino
acid sequence of Dte showed absence of the conserved
amino-terminal cysteine residue (Fig. 3A), but according to
Pearce et al. (1999), this could probably be due to cloning
difficulties. Keeping these concerns in mind, Dte could be
considered as a new gene because of sequence specificity
and expression profiles. At this moment, very little is
known about functional activities of this protein, but
expression patterns of Dte in mice suggest a potential role
during early stages of mouse embryonic development. Dte
expression was first observed in the definitive node at the
early bud stage in a pattern similar to that of Nodal, a
protein required for primitive streak formation and in-
volved in left–right asymmetry. By early somite stage,
strongest Dte expression was seen on the right-hand side of
the node, in contrast with later expression of Nodal, which
is expressed on the left-hand side of the node. Later on in
mouse embryogenesis, Dte expression was no longer ob-
served (Pearce et al., 1999).
Further experiments need to be carried out to study
possible binding to members of the BMP family and to find
out whether Dte is able to inhibit BMP signaling. Pearce et
al. (1999) did already hypothesize a possible role for Dte in
antagonizing Nodal, whereas initially, Dte and Nodal are
expressed symmetrically, but by early somite stage, expres-
sion of both genes becomes biased in a way that Dte
expression is highest at the right, while Nodal is stronger at
the left.
PRDC. Using a gene trap approach in ES cells to identify
genes involved in mouse development, Minabe-Saegusa et
al. (1998) identified a novel mouse gene, PRDC (protein
related to DAN and Cerberus), which showed limited
similarities to DAN and Cerberus. Within the can-domain,
PRDC showed a high degree of sequence similarity with
gremlin, another member of the DAN/Cerberus family (Fig.
2), suggesting possible overlapping or complementary func-
tions. Although PRDC belongs to the DAN/Cerberus fam-
ily based on its structure, thus far, no evidence has been
provided that PRDC can bind and antagonize members of
the BMP family.
During experimental procedures of the gene trapping,
homozygous mice carrying part of the PRDC gene down-
stream of the lacZ gene were generated, which allowed
studying expression patterns of PRDC during mouse devel-
opment. The reporter gene expression was detected in
commissural neurons in the developing spinal cord, sug-
gesting a role for PRDC during mouse neural development.
Expression analysis of endogenous PRDC in these mice is
consistent with patterns seen from the PRDC/lacZ reporter
gene (Minabe-Saegusa et al., 1998).
Homology searches using the BLAST algorithm (Altschul
et al., 1990) with the mRNA sequence of the human PRDC
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gene, encoding a secreted protein of 168 amino acid resi-
dues, assigned the gene to human chromosome 1q42-q43 on
genomic clone RP11–467I20 (GenBank Accession No.
AL358176). To date, no disease has been identified with
mutations in the PRDC gene (Table 4).
Sclerostin
Using a positional cloning strategy to identify the
disease-causing gene in sclerosteosis, a sclerosing bone
dysplasia characterized by a massive bone overgrowth, a
new gene, SOST, was isolated which encodes a protein,
sclerostin, of 213 amino acid residues, with a signal peptide
for secretion (Balemans et al., 2001; Brunkow et al., 2001).
Amino acid sequence analysis demonstrated the conserva-
tion of six cysteine and one glycine residues, which are
essential to form the core cysteine knot, and of two addi-
tional cysteines also seen in the DAN/Cerberus protein
family, the mucins, NDP, the CCN-gene family, and the
gonadotropins (Figs. 3A and 3B). However, based on amino
acid homology, this protein does not belong to the DAN/
Cerberus protein family, because of lack of conservation of
four of the six amino acid residues typical for the can-
domain. Additionally, the conservation of one cysteine
residue, which is found in the DAN/Cerberus protein
family and also in the mucins and NDP, is lacking in
sclerostin (Figs. 3A and 3B). Therefore, we can classify this
protein as a novel member of the cysteine-knot superfamily
of growth factors, but not within the DAN/Cerberus pro-
tein family.
During mouse embryogenesis, SOST expression was de-
tected in the neural tube, limb buds, blood vessels, and
ossifying cartilages in mandible, cervical vertebra, occipital
bone, ribs, and palate, suggesting a possible role of scleros-
tin during mouse development (unpublished data; patent
PCT/US99/27990). In adult human tissues, the expression
pattern was restricted to kidney, bone marrow, and osteo-
blasts differentiated for 21 days, implicating a very select
role for sclerostin in adult life (Balemans et al., 2001). In
situ hybridization experiments on human kidney sections
using a SOST antisense RNA probe showed a restricted
expression in the glomeruli (unpublished data).
In vitro studies demonstrated binding of sclerostin to the
closely related BMP-5 and BMP-6 (Table 3), but not to BMP-4
(unpublished results; patent PCT/US99/27990); however, evi-
dence needs to be provided that sclerostin acts as an antago-
nist for BMPs under physiological conditions. The structure of
sclerostin, with the presence of the cysteine-knot, suggests
direct binding of sclerostin to BMPs in a manner similar to
members of the DAN/Cerberus protein family, and in this
way interfering directly with BMP signaling by inhibiting the
binding to the BMP receptors.
The human SOST gene is located on chromosome 17q12-
q21, in a region where both sclerosteosis (SOST; MIM-
269500) (Balemans et al., 1999) and van Buchem disease
(VBCH; MIM239100) (Van Hul et al., 1998) are located. Both
conditions are craniotubular hyperostoses and display with
similar skeletal abnormalities of a generalized hyperostosis
(Van Buchem et al., 1962; Truswell, 1958). Sclerosteosis
showed additional clinical features, such as a tall stature
and hand malformations (Beighton et al., 1984); however,
both conditions are thought to be allelic (Beighton et al.,
1984). Loss-of-function mutations in SOST were found in
patients with sclerosteosis (Balemans et al., 2001; Brunkow
et al., 2001), and the presence of a deletion 35 kb down-
stream of SOST in patients with van Buchem disease
suggests that this condition is caused by inappropriate
regulation of SOST expression (Balemans et al., 2002)
(Table 4).
Homology searches with the mRNA and protein se-
quences of sclerostin showed weak homology with a new
gene, referred to as SOST-like, located on human chromo-
some 7p21. This gene encodes a secreted protein, sclerostin-
like, containing 206 amino acid residues with a cysteine
knot motif, and also lacking the characteristics of the
can-domain (Fig. 3B). An amino acid homology between
sclerostin and sclerostin-like of 36% is observed. The
identification of these two homologous proteins may sug-
gest the existence of a novel protein family of secreted
growth factors. Further experiments need to be carried out
to elucidate possible roles of these proteins during develop-
ment and in adult tissues.
DISCUSSION AND PERSPECTIVES
The past few years have been exciting for the BMP field,
due to the identification of a class of proteins which
modulate BMP signaling. It is now becoming increasingly
clear that many aspects of development in vertebrates and
invertebrates are regulated by opposing activities of se-
creted ligands and their extracellular antagonists, which
together define the tightly regulated spatiotemporal do-
mains of target activation. In this paper, we reviewed the
current state of the extracellular modulators of BMP signal-
ing in vertebrates. To date, nine extracellular proteins with
BMP binding capacities—noggin, chordin, chordin-like, fol-
listatin, FSRP, DAN, Cerberus, gremlin, and sclerostin—
have been identified, three of which belong to a distinct
protein family: the DAN/Cerberus family. Additionally,
three proteins show significant homology to at least one of
them—Dte, PRDC, and sclerostin-like. For a subset of these
BMP binding molecules, it is known that they bind BMP
family members with different degrees of specificity (Hsu et
al., 1998), and the activities of a large number of these
proteins suggest that they antagonize BMP signaling using a
similar mechanism. This hypothesis is supported by the
finding that noggin, chordin, follistatin, DAN, Cerberus,
and gremlin all bind BMP-2, -4, and -7 (Table 3). Further-
more, noggin efficiently competes with DAN/Cerberus
family members for binding to BMP-2, suggesting that the
interaction between BMP-2 and these antagonists occurs
through a similar BMP domain (Hsu et al., 1998).
For a number of BMP antagonists, it is known that their
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regulation of BMP signaling is not a one-way process.
Feedback mechanisms exist whereby members of the BMP
family modulate their own activity. Distal outgrowth of the
chick limb is, in part, controlled by a regulatory loop
between BMPs and gremlin (Merino et al., 1999b). Induc-
tion of noggin has been observed in cultured rat osteoblasts
and mouse forelimb organ cultures treated with BMP-2 and
BMP-7 (Gazzerro et al., 1998; Nifuji and Noda, 1999).
Noggin expression is also upregulated after incubation of
developing chick somites with BMP-4 (Amthor et al., 1999),
and ectopic expression of follistatin was seen in the devel-
oping chick limb bud after exogenous administration of
GDF-11 (Gamer et al., 2001).
Different findings support the hypothesis that different
BMP antagonists might exhibit overlapping and/or comple-
mentary functions during development. For example, in
early embryogenesis, noggin and chordin single knockout
mice did not show any developmental defects, while
noggin/chordin double knockouts displayed numerous de-
fects during gastrulation, suggesting that both proteins
might be functional equivalents during these early stages of
development (Bachiller et al., 2000).
Studies of expression patterns and mouse models of BMP
antagonists provided huge amounts of information on the
involvement of these molecules in major processes of
development. A key role of the BMP antagonist activities
resides within the organizer during the first stages of
embryonic development, where they are implemented in
the induction and patterning of ventral mesoderm. Several
studies in Xenopus and Drosophila have demonstrated that
the mechanism of dorsal–ventral patterning in both verte-
brate and invertebrate species shares a common plan,
whereby a conserved system of antagonistic extracellular
signals, i.e., sog-chordin/noggin opposed the action of their
ligands, i.e., dpp/screw-BMP-2/-4 (Padgett et al., 1993;
Schmidt et al., 1995; Holley et al., 1995, 1996). In verte-
brates, ventral cell fates are specified by the action of BMPs
and are antagonized by dorsally expressed antagonists. In
invertebrates, the same relationship exists between dpp/
screw and sog, but the axis is inverted. A number of
vertebrate BMP antagonists, such as noggin, chordin, fol-
listatin, and DAN, are expressed nearby in the organizer
and, due to their dorsalizing activities, can act as a defense
mechanism against being ventralized (reviewed in Thom-
sen, 1997). Another important, but still not fully under-
stood, BMP antagonist function is the induction of neural
tissue from the ectoderm and is today a major focus of
interest for embryologists. BMP signals are known to pat-
tern ectoderm during gastrulation, by inducing epidermis
from ectoderm which would otherwise transform into a
neural state (Sasai et al., 1995). The identification of differ-
ent BMP ligands and their counteracting neural fate-
inducing BMP antagonists has led to the establishment of
the “default model” of neurulation in the Xenopus embryo
(Hemmati-Brivanlou and Melton, 1997). To date, five BMP
antagonist molecules are known to be involved in neural
induction in vertebrates: noggin, chordin, follistatin, DAN,
and Cerberus. However, it is now also known that BMP
inhibition by these antagonists is not sufficient for neural
induction, but rather, acts downstream of, or in conjunction
with, other signals from the organizer. Several groups are
currently investigating the involvement of the FGF (fibro-
blast growth factor) and Wnt pathways in specifying neural
fates. It has been shown that both pathways participate in
neural induction, either directly or indirectly through BMP
signaling (Lamb and Harland, 1995; Launay et al., 1996;
Gomez-Skarmeta et al., 2001; Wilson et al., 2001). Al-
though the knowledge about the evolutionary conservation
of neural induction among vertebrates and invertebrates is
still confusing, several recent experimental findings have
tackled the hypothesis of a common plan for neural induc-
tion, because of differences in the time and in the mecha-
nism of specification of neural cells between different
species, while other groups propose a possible unifying
mechanism (reviewed in Wilson and Edlund, 2001; Mun˜oz-
Sanjua´n and Brivanlou, 2002). Studies in Xenopus and
zebrafish clearly indicated a role for several BMP antago-
nists in neural induction; however, single knockout mouse
models of these neural-inducing antagonists did not reveal
any defects in neural induction during early gastrulation
(Table 2). These findings could be explained by the exis-
tence of proteins which are able to rescue the neural
induction process. The generation of multiple (double,
triple, quadruple, or greater combinations) knockout mod-
els, in which different BMP antagonists or a combination of
BMP antagonists and members of the Wnt and FGF path-
ways are knocked out, may provide better insights in the
processes of neural induction. Zuniga et al. (1999) and
Merino et al. (1999a,b) described how antagonistic interac-
tions of noggin, follistatin, and gremlin coordinate the
vertebrate limb proximal–distal specification and the con-
trol of limb bud outgrowth and proliferation by altering
BMP signaling. Besides these three major functions, BMPs
and their antagonists are known to be involved in numer-
ous other processes, indicating the importance of this
control system during different phases of development and
in the patterning and maintenance of adult tissues.
When considering the increasing number of BMP antago-
nists discovered, and the identification of homologues of
the different BMP antagonists, such as chordin-like, FSRP,
and sclerostin-like, it may be clear that these molecules act
in a complex cascade of tightly regulated actions in the
processes of vertebrate and invertebrate patterning. How-
ever, a lot of research still needs to be carried out to
completely solve and understand the entire process of
embryonic development and the involvement of these an-
tagonists in adult tissues.
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